Analysis Links ctDNA Clearance to Improved Outcomes in Advanced Cervical Cancer
OncLive,
Jyoti S. Mayadev, MD Findings from an ultrasensitive circulating tumor DNA (ctDNA) analysis from the phase 3 CALLA trial (NCT0383…
Jyoti S. Mayadev, MD Findings from an ultrasensitive circulating tumor DNA (ctDNA) analysis from the phase 3 CALLA trial (NCT0383…
The risk of progression was reduced with the use of durvalumab/CRT for advanced cervical cancer, according to an exploratory…
Cervical Cancer | Image Credit: © freshidea - stock.adobe.com An exploratory circulating tumor DNA (ctDNA) analysis from the…
Ovarian Cancer | Image Credit: © Sebastian Kaulitzki – stock.adobe.com Ahead of the 2025 ASCO Annual Meeting, which officially…